Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBT: 2013-2024

Historic EBT for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$97.0 million.

  • Wave Life Sciences' EBT rose 12.83% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 14.43%. This contributed to the annual value of -$97.0 million for FY2024, which is 66.71% down from last year.
  • Latest data reveals that Wave Life Sciences reported EBT of -$97.0 million as of FY2024, which was down 66.71% from -$58.2 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' EBT ranged from a high of -$58.2 million in FY2023 and a low of -$161.1 million during FY2022.
  • In the last 3 years, Wave Life Sciences' EBT had a median value of -$97.0 million in 2024 and averaged -$105.4 million.
  • As far as peak fluctuations go, Wave Life Sciences' EBT soared by 63.89% in 2023, and later tumbled by 66.71% in 2024.
  • Yearly analysis of 5 years shows Wave Life Sciences' EBT stood at -$150.8 million in 2020, then climbed by 18.77% to -$122.4 million in 2021, then plummeted by 31.60% to -$161.1 million in 2022, then surged by 63.89% to -$58.2 million in 2023, then crashed by 66.71% to -$97.0 million in 2024.